Hyperfine (HYPR) Leases (2023 - 2026)
Hyperfine posted quarterly Leases of $247000.0 for Q1 2026, down 11.79% year-on-year from $280000.0 in Q1 2025, and down 21.84% on a QoQ basis from $316000.0 in Q4 2025.
Hyperfine (HYPR) has 4 years of Leases data on file, last reported at $247000.0 in Q1 2026.
- For the quarter ending Q1 2026, Leases fell 11.79% year-over-year to $247000.0; the trailing twelve-month figure through Mar 2026 stood at $247000.0 (down 11.79% YoY), and the FY2025 full-year result was $316000.0, down 7.33% from the prior year.
- Leases for Q1 2026 stood at $247000.0, down from $316000.0 in the prior quarter.
- Across five years, Leases topped out at $341000.0 in Q4 2024 and bottomed at $105000.0 in Q3 2024.
- The 4-year median for Leases is $243000.0 (2023), against an average of $231100.0.
- The widest annual swing landed in 2025, when Leases surged 77.14%; it then retreated 11.79% in 2026.
- A 4-year view of Leases shows it stood at $239000.0 in 2023, then jumped by 42.68% to $341000.0 in 2024, then declined by 7.33% to $316000.0 in 2025, then declined by 21.84% to $247000.0 in 2026.
- The last three Leases figures came in at $247000.0 (Q1 2026), $316000.0 (Q4 2025), and $186000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 547.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 99.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 73.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 396.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 155.20 Mn |
| 10 | Hyperfine | 149.47 Mn | 108.20 Mn | 1.98 Mn | 247,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 247,000.00 |
| Dec 31, 2025 | 316,000.00 |
| Sep 30, 2025 | 186,000.00 |
| Jun 30, 2025 | 254,000.00 |
| Mar 31, 2025 | 280,000.00 |
| Dec 31, 2024 | 341,000.00 |
| Sep 30, 2024 | 105,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Mar 31, 2024 | 194,000.00 |
| Dec 31, 2023 | 239,000.00 |